Detalhe da pesquisa
1.
Enabling Routine MHC-II-Associated Peptide Proteomics for Risk Assessment of Drug-Induced Immunogenicity.
J Proteome Res
; 19(9): 3792-3806, 2020 09 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-32786679
2.
Correction to "Enabling Routine MHC-II-Associated Peptide Proteomics for Risk Assessment of Drug-Induced Immunogenicity".
J Proteome Res
; 20(1): 1103, 2021 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33025787
3.
CSF1R inhibition with emactuzumab in locally advanced diffuse-type tenosynovial giant cell tumours of the soft tissue: a dose-escalation and dose-expansion phase 1 study.
Lancet Oncol
; 16(8): 949-56, 2015 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-26179200
4.
End-to-end approach for the characterization and control of product-related impurities in T cell bispecific antibody preparations.
Int J Pharm X
; 5: 100157, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-36687375
5.
Expanding the MAPPs Assay to Accommodate MHC-II Pan Receptors for Improved Predictability of Potential T Cell Epitopes.
Biology (Basel)
; 12(9)2023 Sep 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37759665
6.
Novel in Vivo and in Vitro Pharmacokinetic/Pharmacodynamic-Based Human Starting Dose Selection for Glofitamab.
J Pharm Sci
; 111(4): 1208-1218, 2022 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34953862
7.
Validation of a Dendritic Cell and CD4+ T Cell Restimulation Assay Contributing to the Immunogenicity Risk Evaluation of Biotherapeutics.
Pharmaceutics
; 14(12)2022 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36559166
8.
Enhanced immunogenic potential of cancer immunotherapy antibodies in human IgG1 transgenic mice.
MAbs
; 14(1): 2143009, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36394299
9.
Managing the Impact of Immunogenicity in an Era of Immunotherapy: From Bench to Bedside.
J Pharm Sci
; 110(7): 2575-2584, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33812888
10.
CD20-TCB with Obinutuzumab Pretreatment as Next-Generation Treatment of Hematologic Malignancies.
Clin Cancer Res
; 24(19): 4785-4797, 2018 10 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-29716920
11.
Application of a MABEL Approach for a T-Cell-Bispecific Monoclonal Antibody: CEA TCB.
J Immunother
; 39(7): 279-89, 2016 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-27404941
12.
Pharmacokinetic evaluation of idebenone.
Expert Opin Drug Metab Toxicol
; 6(11): 1437-44, 2010 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-20955109